These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11699827

  • 1. Formulation and evaluation of diclofenac sodium using hydrophilic matrices.
    Rao YM, Veni JK, Jayasagar G.
    Drug Dev Ind Pharm; 2001 Sep; 27(8):759-66. PubMed ID: 11699827
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of in-vitro release and bioavailability of sustained release diclofenac sodium from certain hydrophilic polymers and commercial tablets in beagle dogs.
    Hosny EA, al-Helw AR, al-Dardiri MA.
    Pharm Acta Helv; 1997 Jun; 72(3):159-64. PubMed ID: 9204774
    [Abstract] [Full Text] [Related]

  • 3. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets.
    Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR.
    J Control Release; 1999 Jan 04; 57(1):75-85. PubMed ID: 9863041
    [Abstract] [Full Text] [Related]

  • 4. The effect of polymer blends on release profiles of diclofenac sodium from matrices.
    Samani SM, Montaseri H, Kazemi A.
    Eur J Pharm Biopharm; 2003 May 04; 55(3):351-5. PubMed ID: 12754011
    [Abstract] [Full Text] [Related]

  • 5. Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies.
    Bravo SA, Lamas MC, Salomon CJ.
    Pharm Dev Technol; 2004 May 04; 9(1):75-83. PubMed ID: 15000468
    [Abstract] [Full Text] [Related]

  • 6. Araucaria Gum: Novel Natural Polymer for Controlled Drug Delivery. Development, In Vitro and In Vivo Evaluation of Araucaria Gum Based Matrix Tablets for Controlled Release.
    Naga Durga DH, Lohithasu D, Ramana Murthy Kolapalli V.
    Curr Drug Deliv; 2017 May 04; 14(7):955-967. PubMed ID: 28034362
    [Abstract] [Full Text] [Related]

  • 7. Topical permeation characteristics of diclofenac sodium from NaCMC gels in comparison with conventional gel formulations.
    Mohammed FA.
    Drug Dev Ind Pharm; 2001 Nov 04; 27(10):1083-97. PubMed ID: 11794811
    [Abstract] [Full Text] [Related]

  • 8. Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and hydroxypropylmethylcellulose.
    Dabbagh MA, Ford JL, Rubinstein MH, Hogan JE, Rajabi-Siahboomi AR.
    Pharm Dev Technol; 1999 Aug 04; 4(3):313-24. PubMed ID: 10434277
    [Abstract] [Full Text] [Related]

  • 9. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Sakr A.
    Acta Pol Pharm; 2016 Aug 04; 73(2):439-52. PubMed ID: 27180437
    [Abstract] [Full Text] [Related]

  • 10. Pharmaceutical Product Lead Optimization for Better In vivo Bioequivalence Performance: A case study of Diclofenac Sodium Extended Release Matrix Tablets.
    Shahiwala A, Zarar A.
    Curr Drug Deliv; 2018 Aug 04; 15(5):705-715. PubMed ID: 29165078
    [Abstract] [Full Text] [Related]

  • 11. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A, Ozkan Y, Işimer A.
    Farmaco; 2005 Feb 04; 60(2):171-7. PubMed ID: 15752476
    [Abstract] [Full Text] [Related]

  • 12. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
    Arora P, Mukherjee B.
    J Pharm Sci; 2002 Sep 04; 91(9):2076-89. PubMed ID: 12210054
    [Abstract] [Full Text] [Related]

  • 13. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
    Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, Anju P, Prasanna S.
    Arch Pharm Res; 2007 Feb 04; 30(2):222-34. PubMed ID: 17366745
    [Abstract] [Full Text] [Related]

  • 14. In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets.
    Liu CH, Kao YH, Chen SC, Sokoloski TD, Sheu MT.
    J Pharm Pharmacol; 1995 May 04; 47(5):360-4. PubMed ID: 7494183
    [Abstract] [Full Text] [Related]

  • 15. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH, Taha NF, Badr RM, Mursi NM.
    Drug Discov Ther; 2012 Oct 04; 6(5):269-77. PubMed ID: 23229148
    [Abstract] [Full Text] [Related]

  • 16. Preparation and characterization of Compritol 888 ATO matrix tablets for the sustained release of diclofenac sodium.
    Roberts M, Pulcini L, Mostafa S, Cuppok-Rosiaux Y, Marchaud D.
    Pharm Dev Technol; 2015 Jun 04; 20(4):507-12. PubMed ID: 24354893
    [Abstract] [Full Text] [Related]

  • 17. The influence of thermal treatment on the release behavior of diclofenac sodium from acrylic matrices.
    Azarmi S, Farid D, Azodi-Deylami S, Ghaffari F, Nokhodchi A.
    Pharm Dev Technol; 2005 Jun 04; 10(2):233-9. PubMed ID: 15926672
    [Abstract] [Full Text] [Related]

  • 18. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU, Shah KU, Rehman A, Khan GM.
    Pak J Pharm Sci; 2011 Apr 04; 24(2):183-92. PubMed ID: 21454168
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
    Alsarra IA.
    Boll Chim Farm; 2004 Dec 04; 143(10):359-64. PubMed ID: 15881815
    [Abstract] [Full Text] [Related]

  • 20. Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M.
    Lamoudi L, Chaumeil JC, Daoud K.
    Drug Dev Ind Pharm; 2012 May 04; 38(5):515-20. PubMed ID: 21978389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.